China carries out what multiple outlets describe as the world’s first commercial brain-computer interface (BCI) implant surgery using an invasive, approved device. The system is reported to be called NEO. According to reports, Chinese surgeons implant a small, coin-sized brain chip that records neuronal activity in a patient who has impaired hand mobility linked to a spinal cord injury from a car accident about a decade ago. The procedure is described as the completion of the first commercial surgery using a BCI device that received approval in March, as stated by the Shanghai municipal Science and Technology Commission. After implantation, the device translates recorded brain signals into control of movements delivered through a metal glove worn by the patient, according to one outlet. Overall, the coverage frames the operation as a milestone for China’s neurotechnology efforts and as competition with other emerging BCI programs. Details beyond the patient’s condition, the device’s reported size and function, the March approval, and the glove-based output vary by report, but all accounts describe an invasive commercial implant that enables hand-related movement control.